Related Experiment Video

Updated: May 11, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Relevant Networks involving the p53 Signalling Pathway in Renal Cell Carcinoma

V Medina Villaamil1, G Aparicio Gallego, I Santamarina Caínzos

  • 1INIBIC, CHU A Coruña. A Coruña, Spain;

International Journal of Biomedical Science : IJBS
|May 16, 2013
PubMed
Abstract

Insights

This study reveals two key protein networks in renal cell carcinoma, including pathways for angiogenesis and apoptosis. The p53 tumor suppressor protein interacts with glucose transporter type 4, offering potential new cancer therapy targets.

Area of Science:

  • Oncology
  • Systems Biology
  • Bioinformatics

Background:

  • Renal cell carcinoma (RCC) is the most common kidney cancer.
  • Understanding critical pathways in RCC is essential for improved diagnostics and therapeutics.
  • Integrating regulatory networks with experimental data can elucidate tumor properties.

Purpose of the Study:

  • To construct and analyze protein interaction networks in renal cell carcinoma.
  • To identify key pathways and molecular interactions driving tumor progression.
  • To combine systems biology insights with experimental data for a comprehensive understanding of RCC.

Main Methods:

  • A systems biology approach was employed, integrating immunohistochemistry (IHC) protein expression profiles.
  • STRING and MeV bioinformatics tools were utilized for network analysis.
  • Pearson's correlation coefficient test was used to analyze IHC data from 80 RCC patients.

Main Results:

  • Two distinct protein networks were identified in RCC tumor samples.
  • The first network involves angiogenesis pathways and the apoptosis suppressor BCL2.
  • The second network highlights a negative interaction between the p53 tumor suppressor and glucose transporter type 4.

Conclusions:

  • The identified networks provide insights into cooperative pathway behaviors in RCC.
  • The p53 pathway's role in regulating metabolic pathways and tumor angiogenesis is significant.
  • Further investigation of p53-interacting proteins may lead to novel cancer therapeutic strategies.
Keywords:
glucose transportershypoxiap53 pathwayprotein interactionsrelevant networksrenal cell carcinoma

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...